The brief
The peptide story, reported straight
Last updated
What changed in peptide regulation, safety and evidence this week. Every Friday, independent and seller-free.
What you get
One email a week. What the FDA actually did, what the evidence now shows, and what changed on the status tracker — with the sources so you can check it.
What you will not get
No vendor promotions. No discount codes. No dosing protocols. No sponsored placements dressed as editorial. We sell nothing, and the newsletter is not a funnel to somewhere that does.
Unsubscribing
One click, effective immediately. We never sell or share the list.